2
Clinical Trials associated with JK500Safety and preliminary efficacy of JK500 cell injection in relapsed/refractory pediatric acute myeloid leukemia
Start Date01 Oct 2022 |
Sponsor / Collaborator- |
Safety and Preliminary Efficacy of JK500 Cell Injection in Relapsed/Refractory Pediatric Acute Myeloid Leukemia
This study is a prospective, single-center, single-arm exploratory clinical study, aiming to complete the preliminary clinical observation of 12 children with relapsed/refractory acute myeloid leukemia treated with JK500 cell injection to evaluate the safety of clinical infusion and the initial efficacy of JK500 cell injection in the treatment of children with relapsed/refractory acute myeloid leukemia.
Start Date14 Sep 2022 |
Sponsor / Collaborator- |
100 Clinical Results associated with JK500
100 Translational Medicine associated with JK500
100 Patents (Medical) associated with JK500
100 Deals associated with JK500